Fampridine-SR: Acorda began 2 North American Phase III trials of Fampridine-SR to treat spasticity associated with spinal cord injury in a total of 360 patients

Acorda Therapeutics Inc., Hawthorne, N.Y.
Product: Fampridine-SR
Business: Neurological

Read the full 92 word article

How to gain access

Continue reading with a
two-week free trial.